RxDoctor Payments Data

Daisy Tint

Family Medicine · Irvine, CANPI 1649251158

Payments from drug & device makers

$2,372in general payments, 2019–2025

Across 137 payments — averaging $17.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$397
  • AstraZeneca$378
  • Lilly USA, LLC$300
  • Merck$199
  • Novo Nordisk$191
  • Boehringer Ingelheim$187
  • plus $720 from 13 others

What the payments were for

  • Food & beverage$2,362100%
  • Education$110%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Pfizer17$397
AstraZeneca(2 entities)24$378
Lilly USA, LLC20$300
Merck13$199
Novo Nordisk13$191
Boehringer Ingelheim4$187
Sanofi-aventis U.S. LLC10$154
GSK11$120
Gilead5$118
Johnson & Johnson7$99
Sanofi Pasteur Inc.4$61
AbbVie(2 entities)2$35
Amarin Pharma, Inc.1$24
Medtronic1$22
Amgen1$19
Metuchen Pharmaceuticals1$19
Abbott1$18
Sunovion Pharmaceuticals Inc.1$16
Bayer1$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,372 in reported general payments places this provider in the 80th percentile of 10,533 family medicine providers in California.

See all family medicine providers in California

Other family medicine in Irvine

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →